The pandemic heightened the need for agility and resiliency within the supply chain, and speed to market remains a top business imperative.
How can you accelerate your digitalization journey? A step-by-step approach is right at your fingertips.
Today’s pharmaceutical manufacturers face increasing pressure to deliver high-quality medicines quickly, efficiently and economically while complying with regulatory requirements and meeting sustainab...
VideoHow are you keeping up with growing demand? Digitalize batch execution and records with Aspen Production Execution Manager™ to accelerate time-to-market with accuracy while maintaining regulatory comp...
Interactive InfographicSpeed to market remains a key driver for the digitalization of long-standing paper-based processes in drug manufacturing. Bottlenecks such as manual execution and review—all associated with bloated do...
On Demand WebinarManaging the master schedule for pharmaceutical production is like riding a roller coaster — with both calm periods and high-velocity swings. It requires making complex decisions daily in response to ...
On Demand WebinarIn this interview, Cade VanRooyen describes the complex decisions master schedulers face and how digital scheduling solutions can significantly improve the consistent on-time delivery of life-saving m...
Interview with an ExpertBuilding resilient and future-proofed supply chains require implementing technology that can bring people and processes together. Industrial AI can play a role in both alleviating current supply chain...
ArticlePharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laborat...
On Demand WebinarFerring Pharmaceuticals, a multinational biopharmaceutical company, needed a solution that would enable faster commercialization, more cost-efficient production and reduced supply lead time while main...
Case StudyPharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supp...
White PaperIncreasingly, the conventional ways of maintaining pharmaceutical equipment call for a digital alternative. Non-wear-based failures such as operating excursion and changes in operation plans make up t...
On Demand WebinarAspen Mtell is a prescriptive maintenance solution that uses Agents to recognize asset failures earlier and with greater accuracy. Learn what an Agent is, what they do, how they are created, and how t...
VideoGlaxoSmithKline (GSK) implemented Aspen Mtell® to increase the robustness of their pharma supply chains by preventing unplanned production downtime.
Case StudyThe 2022 ISPE Biotech event in Boston, MA, was a great opportunity to take the pulse of the current and future outlook on biopharmaceutical manufacturing and therapeutics.
BlogPharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of ...
ReportIn this article for European Pharmaceutical Manufacturer, Richard Porter, AspenTech Pharmaceutical Director looks at how automated technologies are helping pharma companies transform their manufacturi...
ArticleIn the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to su...
White PaperPharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supp...
White PaperThe COVID-19 pandemic highlighted the need for agility and resiliency within the supply chain for pharmaceutical companies. It is clear that speed to market will remain a top business imperative as w...
Executive BriefIn this article from European Pharmaceutical Review, David Leitham, Senior Vice President and General Manager at AspenTech®, explains how implementing PAT pushes the industry towards Pharma 4.0. Downl...
Article